3 результатов для:
02/26/2021
UNICEF handed over 223 refrigerated vehicles to the Government of Uzbekistan
https://www.unicef.org/eca/unicef-handed-over-223-refrigerated-vehicles-government-uzbekistan
Today, UNICEF handed over 223 refrigerated vehicles to the Government of Uzbekistan. The vehicles support the Government’s efforts to strengthen the country’s immunization cold chain and will ensure vaccines are kept at optimal cold temperatures needed to retain their effectiveness when are delivered to regional and district health centres across the country. Uzbekistan’s Deputy Prime Minister, Mr. Behzod Musaevm, accompanied by the Minister of Health, Dr. Abdukhakim Khadjibaev, presided over the handover ceremony was, noted that the consignment of vehicles was timely. Earlier, the Government of Uzbekistan had announced the first shipment of AstraZeneca COVID-19 vaccines, was due to arrive in coming days. UNICEF Representative, Mr. Munir Mammadzade said, “The COVID-19 pandemic has accelerated UNICEF’s push for to make vaccines available to all within the framework of the Health System Strengthening Programme.” The vehicles are valued at more than USD 2 million and was supported by the Global Alliance for Vaccines and Immunization (GAVI). Over the last 3 years UNICEF and partners have invested nearly USD 20 million to support the Ministry of Health to strengthen the country’s national immunization programme. UNICEF supported the construction of vaccine warehouses at national, regional and district levels, helped procure and install cold rooms, freezers and refrigerators, and vehicles to transport of vaccine. As well, UNICEF supported the Ministry of Health in the development of Uzbekistan’s vaccine logistic management information system. The current efforts are historically significant and will improve the national immunization system and in the context of COVID-19 vaccination roll-out, and well beyond. COVAX is co-led by Gavi, the Vaccine Alliance, the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI), working in partnership with UNICEF as well as the World Bank, civil society organisations, manufacturers, and others.
06/16/2021
UNICEF signs supply agreement for Sputnik V COVID-19 vaccine
https://www.unicef.org/eca/press-releases/unicef-signs-supply-agreement-sputnik-v-covid-19-vaccine
 UNICEF and Human Vaccine (Limited Liability Company), a wholly-owned subsidiary of the Russian Direct Investment Fund (RDIF), today announced a long-term agreement (LTA) for the supply of the Sputnik V COVID-19 vaccine. This is the fourth long-term supply agreement UNICEF has signed with a COVID-19 vaccine manufacturer. So far this year, UNICEF has signed such agreements with the Serum Institute of India, Pfizer and AstraZeneca. Procurement by UNICEF under this agreement is conditional on the product achieving an Emergency Use Listing from WHO, to confirm the quality, safety and efficacy of the vaccine.  In addition, an Advance Purchase Agreement (APA) with Gavi, the Vaccine Alliance, will also be needed for procurement to begin on behalf of the COVAX Facility. Should the COVAX Facility decide to enter into an advance purchase agreement for the supply of the Sputnik V vaccine, UNICEF will be ready to deliver as soon as regulatory milestones have been met. At this point, UNICEF through this LTA, stands ready to access up to 220 million doses of the vaccine available for supply in 2021, to meet country demand.  The Sputnik V vaccine consists of two different components of the vaccine to be administered 21 days apart. An exact delivery schedule will be determined in collaboration with the manufacturer. UNICEF’s priority is to make sure that all countries have safe, fast and equitable access to COVID-19 vaccine and to help them prepare for the rollout of immunization.  The best way to bring the pandemic under control is to ensure that safe and effective vaccines are made available as widely as possible and as quickly as possible, reducing inequity by ensuring that no country or territory is left behind due to its economic status. On 24 February 2021, COVID-19 vaccine vials are produced for the COVAX facility at a manufacturer in Pune, a city located in the western Indian state of Maharashtra. UNICEF/UN0421679?Singh